Decrease of interferon gamma serum levels in patients with chronic hepatitis C

Biomedicine and Pharmacotherapy

Volumn 51, Issue 9, 1997, Pages 391-396

  Malaguarnera, M ^a   Di Fazio, I ^a   Laurino, A ^a   Pistone, G ^a   Restuccia, S ^a   Trovato, B A ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Chronic hepatitis C virus; Histological activity index (HAI); Interferon gamma

Indexed keywords

GAMMA INTERFERON;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; HEPATITIS C; HISTOLOGY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030667128     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(97)89432-2     Document Type: Article

References (21)

1. 1 Becker-Andre M, Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR): a novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res 1989;17:9437-46
2. 2 Collart MA, Belin D. Vassalli JA, De Kossado S, Vassalli P. Gamma-Interferon enhances macrophages transcription of the tumor necrosis factor/cachectin, interleukin 1 and urokinase genes, which are controlled by short-lived repressors. J Exp Med 1986;164:2113
3. 3 Desmet VJ, Gerber M, Hoofnagle JH et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20
4. 4 Hagiwara H, Hayashi N, Mita E et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy. Gastroenterology 1993;104:877-83
5. 5 Hagiwara H, Hayashi N, Mita E et al. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 1993;17:545-50
6. 6 Hardy KJ, Sawada T. Human gamma-interferon strongly upregulates its own expression in peripheral blood lymphocytes. J Exp Med 1989;170:1021
7. 7 Iwata K, Wakita T, Okumura A, Yoshioka K, Takayanagi M, Wands JR, Kakumu S. Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology 1995;22(4):1057-64
8. 8 Izzo F, Cremona F, Ruffolo F, Palaia R, Parisi V, Curley S. Detection of epatocellular cancer during screening of 1125 patients with chronic hepatitis virus infection. J Chemotherapy 1997;9(2):151-2
9. 9 Jirillo E, Greco B, Caradonna L et al. Evaluation of cellular immune responses and soluble mediators in patients with chronic hepatitis C virus (cHCV) infection. Immunopharmacol Immunotoxicol 1995;17(2):347-64
10. 10 Lohr HF, Schlaak JF, Gerken G, Fleisher B, Dienes HP, Meyer-zum-Buschenfelde KJ. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994;14:161-6
11. 11 Lorsbach RB, Murphy WJ, Lowenstein CJ, Snyder SH, Russel SW. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. J Biol Chem 1993;268:1908-13
12. 12 Malaguarnera M, Restuccia S, Trovato G, Siciliano R. Motta M, Trovato BA. Interferon alpha treatment in patients with chronic hepatitis C. A meta-analytic evaluation. Clin Drug Invest 1995;9:141-9
13. 13 Mihm S, Hutschenreiter A, Fayyazi A, Pingel S, Ramadori G. High inflammatory activity is associated with an increased amount of IFN-γamma transcripts in peripheral blood cells of patients with chronic hepatitis C virus infection. Med Microbiol Immunol 1996;185(2):95-102
14. 14 Missale G, Ferrari C, Fiaccadori F. Cytokine mediators in acute inflammation and chronic course of viral hepatitis. Ann Ital Med Int 1995;10:14-8
15. 15 Morshed SA, Fukuma H, Kimura Y, Watanabe S, Nishioka M. Interferon-gamma, Interleukin (IL-) 2 and IL-2 receptor expression in hepatitis C virus-infected liver. Gastroenterol Jpn 1993;5:59-66
16. 16 Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type-speeific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-9
17. 17 Quiroga JA, Martin J, Pardo M, Carreno V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha. Dig Dis Sci 1994;39(11):2485-96
18. 18 Steinman RM, Noguiera N, Witmer MA, Tyding JG, Mellman IS. Lymphokine enhances the expression and synthesis of Ia antigens on cultural mouse peritoneal macrophages. J Exp Med 1980;152:1248-61
19. 19 Turano A, Balsari A, Viani E, Landolfo S, Zanoni L, Gargiulo F, Caruso A. Natural human antibodies to gamma Interferon interfere with the immunomodulating activity of the lymphokine. Proc Natl Acad Sci USA 1992;8(9):4447-5I
20. 20 Turano A, Caruso A. The role of human autoantibodies against gamma-interferon. J Antimicrob Chemother 1993;32(Suppl A):99-105
21. 21 Wakita T, Kakumu S, Yoshioka K, Ishikawa T, Ito Y, Shinagawa T. Cellular immune response of peripheral blood mononuclear cells to HBV antigens during chronic and acute HBV infection. Digestion 1992;52:26-33